Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.

[1]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[2]  J. Rosenberg,et al.  Targeting angiogenesis in bladder cancer , 2009, Current oncology reports.

[3]  S. Donat,et al.  Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  R. Hautmann,et al.  Open to debate. The motion: perioperative chemotherapy in muscle invasive bladder cancer improves survival. , 2008, European Urology.

[5]  Peter A. Jones,et al.  Molecular targets and targeted therapies in bladder cancer management , 2008, World Journal of Urology.

[6]  Y. Lotan,et al.  Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness , 2007, Modern Pathology.

[7]  Y. Lotan,et al.  Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. , 2006, Human pathology.

[8]  Yair Lotan,et al.  Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. , 2006, The Journal of urology.

[9]  S. Groshen,et al.  Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. , 2006, The Journal of urology.

[10]  Peter A. Jones,et al.  Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer , 2005, Nature Clinical Practice Urology.

[11]  R. Millikan,et al.  Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. , 2004, The Journal of urology.

[12]  C. Billottet,et al.  Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2 , 2002, Oncogene.

[13]  A. Harris,et al.  Angiogenesis in bladder cancer--prognostic marker and target for future therapy. , 2002, Surgical oncology.

[14]  G. Adessi,et al.  Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer. , 2001, The Journal of urology.

[15]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Gallucci,et al.  Detection of basic fibroblast growth factor mRNA in urinary bladder cancer: correlation with local relapses. , 1999, International journal of oncology.

[17]  H. Miyake,et al.  Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line. , 1998, Cancer letters.

[18]  A. Harris,et al.  Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. , 1997, Cancer research.

[19]  S. Groshen,et al.  Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. , 1997, Journal of the National Cancer Institute.

[20]  A. Harris,et al.  Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer. , 1997, Cancer research.

[21]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[22]  S. Groshen,et al.  Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. , 1995, Journal of the National Cancer Institute.

[23]  P. Carroll,et al.  Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. , 1995, The Journal of urology.

[24]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[25]  P. Steeg,et al.  Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. , 1994, Cancer research.

[26]  P. Steeg,et al.  Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines , 1994, International journal of cancer.

[27]  D. Givol,et al.  Induction of WAF1/CIP1 by a p53-independent pathway. , 1994, Cancer research.

[28]  S. Kumar,et al.  Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. , 1994, Journal of the National Cancer Institute.

[29]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[30]  P. Maher,et al.  Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line , 1993, Journal of cellular physiology.